RS3 ESTIMATING THE COST-EFFECTIVENESS OF FLUTICASONE PROPIONATE FORTREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Authors :: Sally Spencer
YM Gagnon
Geraldine Bale
Andrew Briggs
H Wang
S Burge
Michael D. Spencer
Source :: Value in Health. 8:246-247
Publication Year :: 2005
Publisher :: Elsevier BV, 2005.

Subjects :: medicine.medical_specialty
Cost effectiveness
business.industry
Health Policy
Internal medicine
Public Health, Environmental and Occupational Health
medicine
Pulmonary disease
business
Fluticasone propionate
medicine.drug

Full Text Access

Tools